Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Cetuximab in Combination With External Beam Radiation Followed By Consolidation Chemotherapy for Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00492206 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00492206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00492206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Cetuximab in Combination With External Beam Radiation Followed By Consolidation Chemotherapy for Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2006
Completion date
February 29, 2012
Enrollment
40 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer (nsclc)